NCT04672434 2024-12-09Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSymphogen A/SPhase 1 Completed48 enrolled
NCT04793815 2023-06-29Lung Cancer Cryo-Activation as a Novel Approach to Augment Immunotherapy Efficacy (CRYOVATE)Centre hospitalier de l'Université de Montréal (CHUM)Phase NA Completed15 enrolled
NCT02890069 2023-01-11A Study of PDR001 in Combination With LCL161, Everolimus or PanobinostatNovartisPhase 1 Completed298 enrolled
NCT02404441 2022-08-03Phase I/II Study of PDR001 in Patients With Advanced MalignanciesNovartisPhase 1/2 Completed319 enrolled 41 charts
NCT03365791 2022-05-27PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic MalignanciesNovartisPhase 2 Completed76 enrolled 14 charts
NCT02900664 2022-03-29A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)NovartisPhase 1 Completed283 enrolled
NCT02947165 2022-01-31Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.NovartisPhase 1 Completed120 enrolled
NCT03647488 2022-01-24Study of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung CancerNovartisPhase 2 Completed18 enrolled 23 charts